Showing results (411-420 of 831) with videos related to

Sort By:
Pageof 84
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
A case of bilateral alternating hemifacial spasmsJ B van de Biezenbos, M W Horstink, C J van de Vlasakker, et al.
Journal of Neuromuscular Diseases|October 30, 2018
Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch PracticeT B M Tilanus, J T Groothuis, J M C Ten Broek-Pastoor, et al.
Molecular Reproduction and Development|March 26, 2008
MMP-2 expression precedes the final ripening process of the bovine cervixE van Engelen, V N A Breeveld-Dwarkasing, M A M Taverne, et al.
The Journal of Pain|March 31, 2018
Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2Judith van Vliet, Alide A Tieleman, Aad Verrips, et al.
Molecular Genetics and Metabolism|April 13, 2016
Pathogenicity of novel ABCD1 variants: The need for biochemical testing in the era of advanced geneticsMartin J A Schackmann, Rob Ofman, Björn M van Geel, et al.
Regulatory Toxicology and Pharmacology : RTP|December 13, 2005
Consumer product in vitro digestion model: Bioaccessibility of contaminants and its application in risk assessmentEsther F A Brandon, Agnes G Oomen, Cathy J M Rompelberg, et al.
Disability and Rehabilitation|April 16, 2024
The capability approach in rehabilitation: developing capability careEirlys J Pijpers, Bart Bloemen, Edith H C Cup, et al.
Regulatory Toxicology and Pharmacology : RTP|May 12, 2004
Role of biokinetics in risk assessment of drugs and chemicals in childrenL L de Zwart, H E M G Haenen, C H M Versantvoort, et al.
European Journal of Human Genetics : EJHG|May 31, 2012
Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2Erik-Jan Kamsteeg, Wolfram Kress, Claudio Catalli, et al.
Pageof 84